Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes

Author: Pogliani E.M.   Rossini F.   Pioltelli P.   Bolis S.   Borin L.   Casaroli I.   Lanzi E.   Maffè P.   Parma M.   Tripputi P.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.15, Iss.5, 1998-05, pp. : 425-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract